Catella AB
F:SKVB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Catella AB
F:SKVB
|
SE |
|
C
|
China Tower Corp Ltd
OTC:CHWRF
|
CN |
|
Remy Cointreau SA
PAR:RCO
|
FR |
|
Martin Midstream Partners LP
NASDAQ:MMLP
|
US |
|
4D Molecular Therapeutics Inc
NASDAQ:FDMT
|
US |
|
Dorel Industries Inc
F:DO4B
|
CA |
|
InMed Pharmaceuticals Inc
NASDAQ:INM
|
CA |
|
PLDT Inc
NYSE:PHI
|
PH |
|
M
|
Mpact Ltd
JSE:MPT
|
ZA |
Wall Street
Price Targets
SKVB Price Targets Summary
Catella AB
According to Wall Street analysts, the average 1-year price target for
SKVB
is 3.121 EUR
with a low forecast of 2.248 EUR and a high forecast of 4.089 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is SKVB's stock price target?
Price Target
3.121
EUR
According to Wall Street analysts, the average 1-year price target for
SKVB
is 3.121 EUR
with a low forecast of 2.248 EUR and a high forecast of 4.089 EUR.
What is Catella AB's Revenue forecast?
Projected CAGR
5%
For the last 9 years the
compound annual growth rate for
Catella AB's revenue is
0%.
The projected
CAGR
for the next 3 years is
5%.
What is Catella AB's Operating Income forecast?
Projected CAGR
4%
For the last 9 years the
compound annual growth rate for
Catella AB's operating income is
3%.
The projected
CAGR
for the next 3 years is
4%.
What is Catella AB's Net Income forecast?
Projected CAGR
67%
For the last 9 years the
compound annual growth rate for
Catella AB's net income is
-18%.
The projected
CAGR
for the next 3 years is
67%.
